This inventor holds 2 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignees: First-Citizens Bank & Trust Company, Illumina Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Aaron Wise
Introduction
Aaron Wise is an accomplished inventor based in San Diego, CA. He holds 2 patents that reflect his contributions to the fields of cancer treatment and peptide analysis. His work demonstrates a commitment to advancing medical technology and improving patient outcomes.
Latest Patents
Among his latest patents is a groundbreaking invention titled "N-TERMINAL MODIFIER AGENTS AND BINDERS FOR TREATING AND ANALYZING PEPTIDES." This patent focuses on innovative methods for analyzing peptides, which are crucial in various biological processes. Another significant patent is a method for administering a cancer treatment. This invention includes a computer-implemented method that utilizes a trained machine learning classifier to analyze genomic information from tumor samples. The classifier predicts a subject's responsiveness to checkpoint inhibition treatment, thereby enhancing personalized medicine approaches.
Career Highlights
Aaron has worked with notable companies such as Illumina Corporation and First-Citizens Bank & Trust Company. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in healthcare technology.
Collaborations
Aaron has collaborated with talented individuals in his field, including Vitor Ferreira Onuchic and Soumya Ganguly. These partnerships have fostered a creative environment that encourages the exchange of ideas and expertise.
Conclusion
Aaron Wise's contributions to innovation in cancer treatment and peptide analysis highlight his role as a significant inventor in the medical technology landscape. His patents and collaborations reflect a dedication to improving healthcare through advanced technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
